Recurrence-free survival did not reach statistical significance when the PRS was used to assess the benefit to patients of receiving neoadjuvant chemotherapy alone ( Figure S25 E).
← all excerpts
Comprehensive multi-omics analysis of pyroptosis for optimizing neoadjuvant immunotherapy in patients with gastric cancer.
1
—
—